| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Dec, 2021 | Jun, 2021 | Mar, 2021 |
| Sales | 2,925 | 931 | 2,218 | 1,721 | 0 |
| Sales Growth | +214.11% | -58.02% | +28.84% | unch | unch |
| Net Income | -497 | -2,945 | -2,448 | -5,266 | -4,495 |
| Net Income Growth | +83.14% | -20.30% | +53.51% | -17.16% | -685.03% |
Levitee Labs Inc (LVT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Levitee Labs Inc is a functional mushroom company, focused on developing and selling high-potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company believes, based on a growing body of research, that mushrooms can be an effective way to enhance well-being and potentially treat various kinds of mental and physical health problems. The company's reportable segments are; the Medical services segment, which provides medical treatment; and the Selling products segment which is into buying and selling products. Substantial revenue is generated from Medical services operations.
Fiscal Year End Date: 09/30